Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05327712 · ClinicalTrials.gov registry record · NA

Using Emails and Personalized Phone Calls to Increase Affordable Care Act Marketplace Enrollment Among Households Losing Medicaid

A NA study of Health Behavior, sponsored by Office of Evaluation Sciences.

Completed
Registry status
NA
Development phase
2,173
Enrollment target
1
Study location

NCT05327712 is a NA study of Health Behavior that has completed, run by Office of Evaluation Sciences. The registered enrollment target is 2,173 participants, roughly in line with the 2,152-participant average among 65 other Health Behavior trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05327712, a NA study of Health Behavior, has completed, sponsored by Office of Evaluation Sciences.

COMPLETED
Registry status
NA
Development phase
2,173 participants
Enrollment target
1
Study location

Study Summary

Since its passage in 2010, the Affordable Care Act (ACA) has helped reduce the uninsured rate to record lows, but changes in insurance coverage over time, known as churn, remain a concern. A recent survey found that nearly 25 percent of respondents reported a change in coverage over the previous twelve months. Among the most common reasons for churn is the loss of Medicaid eligibility, placing low-income populations at risk of a coverage gap. To date, little evidence exists on effective strategies states can use to facilitate Medicaid to Marketplace coverage transitions, an issue that has become more pressing amid projections that upwards of 15 million people could lose Medicaid eligibility once the COVID-19 public health emergency expires. To address this gap and to inform Marketplace administrators, during a Special Enrollment Period (SEP) in 2017 in California's ACA Marketplace, we conducted a randomized controlled trial to examine the effect of email reminders, personalized telephone outreach, as well as the combination of the two forms of outreach on ACA enrollment among households who recently lost Medicaid and became eligible for subsidized Marketplace coverage. During the SEP at the end of August 2017, the investigators randomly assigned households to one of four arms based on the last digit of their household identifier: a control group assigned to receive no outreach beyond an initial eligibility determination notice; an email-only group assigned to receive an initial eligibility determination plus email reminders about signing up for marketplace coverage; a phone-only group assigned to receive an initial eligibility determination plus a phone call offering enrollment assistance from a service center representative (SCR); a phone + email group assigned to receive an initial eligibility determination, email reminders about signing up for marketplace coverage and a phone call offering enrollment assistance.

Conditions Studied

Interventions

  • BEHAVIORAL Control group
  • BEHAVIORAL Email only
  • BEHAVIORAL Phone only
  • BEHAVIORAL Phone and email

Study Locations (1)

California

  • Covered California - Sacramento

Trial Details

FieldValue
Enrollment Target 2,173 participants
Start Date 2017-08-30
Est. Completion 2017-11-17
Phase NA

Sponsor

Office of Evaluation Sciences

3 total trials

What the Registry Record Tells You About NCT05327712

The ClinicalTrials.gov registry entry for NCT05327712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,173 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,152-participant average among 65 other Health Behavior trials with a reported enrollment target. The listed sponsor is Office of Evaluation Sciences, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 4 interventions - of which Control group is the first listed.

NCT05327712 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05327712 about?

NCT05327712 is a clinical study titled "Using Emails and Personalized Phone Calls to Increase Affordable Care Act Marketplace Enrollment Among Households Losing Medicaid". Since its passage in 2010, the Affordable Care Act (ACA) has helped reduce the uninsured rate to record lows, but changes in insurance coverage over time, known as churn, remain a concern. A recent survey found that nearly 25 percent of respondents reported a change in coverage over the previous twe...

What is the current status of trial NCT05327712?

This trial is currently completed. It is a NA study. The enrollment target is 2,173 participants. The study started on 2017-08-30. Estimated completion is 2017-11-17.

What conditions does trial NCT05327712 study?

This clinical trial studies the following conditions: Health Behavior.

What interventions are being tested in trial NCT05327712?

The interventions under investigation include: Control group (BEHAVIORAL), Email only (BEHAVIORAL), Phone only (BEHAVIORAL), Phone and email (BEHAVIORAL).

Who is sponsoring clinical trial NCT05327712?

This trial is sponsored by Office of Evaluation Sciences, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05327712 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.